During follow-up, nine of the patients were at some time exposed to NSAIDs, and eight were treated by Etanercept, a BL that treats autoimmune diseases by interfering with tumor necrosis factor (TNF) (a soluble inflammatory cytokine) by acting as a TNF inhibitor. This evidence concerns the gene TNF and autoimmune disease.